Sign in
Taking people in United StatesEarly phase 1

Sleep Therapy for Insomnia in Adults with Type 1 Diabetes

Tests a sleep therapy for insomnia in adults with type 1 diabetes.

Key facts

Who runs it
University of Illinois Chicago
Where
Chicago, United StatesSee the site
Trial code
Registry title
CBTi for the Treatment of Insomnia in Type 1 Diabetes
Status
Recruiting
Phase
Early phase 1
People taking part
15 people, planned
Started
1 Dec 2025
Expected to end
30 Jun 2027
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • Sleep quality improvement therapy
  • Healthy Living
Record updated
6 October 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults aged 18 to 65 with type 1 diabetes who have poor sleep and use a continuous glucose monitor. It tests a sleep therapy against a healthy living program.

Age
18 to 65 years
Sex
All sexes can join.
Disease stage
Type 1 diabetes diagnosed at least 1 year ago, with poor sleep quality.
Earlier treatment
People who take medications for sleep cannot join.

Main reasons for not taking part

  • Currently pregnant, planning pregnancy or breast feeding
  • Rotating or night shift work
  • High risk for obstructive sleep apnea
  • Moderately severe to severe depression
  • Serious medical history such as heart failure, cirrhosis, COPD, stroke with neurological deficits or kidney failure needing dialysis

The registry criteria, word for word

Show all 12 criteriaShow less

Who can take part

  • Between 18 to 65 years old
  • Have been diagnosed with Type 1 Diabetes for at least a year
  • Use a continuous glucose monitor
  • Have poor sleep quality
  • Able to attend 3 office visits

Who cannot take part

  • Non-English speaking (unable to participate in therapy or questionnaire)
  • Take medications for sleep
  • Have a significant medical history that includes conditions like heart failure, cirrhosis, COPD, diseases requiring oxygen, active treatment for cancer or psychiatric problems, history of stroke with neurological deficits, cognitive impairment, kidney failure that requires dialysis, illicit drug use, use of ADHD stimulant medications
  • Currently or planning pregnancy or breast feeding
  • Employed with a rotating or night shift
  • Are at a high risk for obstructive sleep apnea
  • moderately severe to severe depression

Check if you might fit

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 65 years old?

Where in United States

  • University of Illinois ChicagoChicago, United StatesContact: Jennifer Duffecy, PhDTaking people

About the trial

What the trial wants to find out

The goal of this study is to learn if treating insomnia with a therapy intervention in people with type 1 diabetes will help to better control sugar levels, sleep, and quality of life. The questions this study aims to answer include:

Read full original descriptionShow less

Will this intervention help the insomnia symptoms? Will obtaining better sleep aid in the control of diabetes through measures like sugar levels? Will the intervention help with quality of life factors like mood and fatigue?

Researchers will compare participants receiving the therapy intervention for sleep with those in the "healthy living" intervention to see if the outcomes are different based on the treatment.

Participants in the therapy intervention group will:

* meet virtually with a therapist for 8 sessions via Zoom. Once a week for the first 4 weeks and then every other week for the last 4 sessions.

Participants in the healthy living group will:

* receive weekly health education emails * receive brief weekly calls from a coach to answer any questions

Participants, regardless of intervention, over the 12 week study period will:

* monitor their sleep for 2 weeks through a sleep-monitoring watch * share their continuous glucose monitoring data throughout the study * answer questionnaires prior to the intervention, halfway through the intervention and then after the intervention * attend 3 in person office visits

The 2 groups in the trial

  • Cognitive Behavioral Therapy Intervention for InsomniaTreatment being tested

    Virtual CBTi sessions will be tailored to be address the specific challenges that come with type 1 diabetes.

    Treatment: Sleep quality improvement therapy

  • Healthy LivingExisting treatment, for comparison

    Psychoeducation about general health and sleep alongside brief calls from a coach will be provided.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.
Official title
CBTi for the Treatment of Insomnia in Type 1 Diabetes
Plain-language title
Sleep Therapy for Insomnia in Adults with Type 1 DiabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 12 November 2026.
Fit questions
Built from NCT07091318, who can take part
Record updated
6 October 2026